Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
Information source: Stanford University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Fetal Distress
Intervention: nitroglycerin and terbutaline (Drug)
Status: Active, not recruiting
Sponsored by: Stanford University
Official(s) and/or principal investigator(s):
Yasser Yehia El-Sayed, Principal Investigator, Affiliation: Stanford University
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation
Official title: Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
Study design: Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment
Primary outcome: resolution of abnormal fetal heart tracing
cesarean section rate
operative vaginal delivery rate
Minimum age: 18 Years.
Maximum age: N/A.
- nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease,
placental abruption, intrauterine growth restriction, prior cesarean section
Locations and Contacts
Stanford University School of Medicine, Stanford, California 94305, United States
Last updated: May 7, 2008